Atlas Trials

Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma

Clinical trial NCT04996459 · UNKNOWN

Trial details

NCT number
NCT04996459
Sponsor
Fudan University
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2020-03-01
Primary completion
2021-06-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.